$IMMP Reveals New Findings from Mid-Stage Study Testing Combo IMP321 + $MRK 's KEYTRUDA in Head and Neck Squamous Cell Carcinoma and Non-Small Cell Lung Cancer Patients  #Immutep    #Merck   #HNSCC   #NSCLC      #Carcinoma     #LungCancer     #Cancer      https://t.co/IU8GSFZZox